Excellent long-term survival in patients with early-stage primary bone lymphoma treated with doxorubicin-based chemotherapy and local radiotherapy

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 6, 2002, Pages 603-605

  Stein, Moshe Efraim ^a   Epelbaum, Ron ^a   Zaidan, Jamal ^c   Kuten, Avraham ^a   Ben Schachar, Menachem ^b   Haim, Nissim ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Nahariya Hospital Israel   (Israel)

^c Rebecca Sieff Government Hospital   (Israel)

Author keywords

Chemoradiotherapy; Early stage; Excellent survival; Primary bone lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; PREDNISONE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPHOMA; MALE; OSTEOSARCOMA; RADIATION DOSE; RETROSPECTIVE STUDY; SEPSIS; STOMATITIS; TREATMENT OUTCOME; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PREDNISONE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VINCRISTINE;

EID: 0036898484     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200212000-00016     Document Type: Article

References (9)

1. Ostrowski ML, Unni KK, Banks PM, et al. Malignant lymphoma of bone. Cancer 1986;58:2646-55.
2. Rathmell AJ, Gospodarowicz SB, Sutcliffe RM, et al., and The Princess Margaret Hospital Lymphoma Group. Localised lymphoma of bone, prognostic factors and treatment recommendations. Br J Cancer 1992;66:603-6.
3. Barr J, Burkes SL, Bell R, et al. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 1994;73:1194-9.
4. Loeffler JS, Tarbell NJ, Kozakewich H, et al. Primary lymphoma of bone in children: Analysis of treatment results with Adriamycin, prednisone, Oncovin (APO), and local radiation therapy. J Clin Oncol 1986;4:496-501.
5. Dubey P, Ha CS, Besa PC, et al. Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys 1997;37:1087-93.
6. Mendenhall NP, Jones JJ, Kramer BS, et al. The management of primary lymphoma of bone. Radiother Oncol 1987;9:137-45.
7. Zucca E, Roggero E, Bertoni F, et al. Primary extranodal nonHodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites [Review]. Ann Oncol 1999;10:1023-33.
8. Malawer MM, Link MP, Donaldson SS. Sarcomas of bone. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer, Principles & Practice of Oncology. 6th Ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1891-934.
9. Sutcliffe SB, Gospodarowicz MK. Clinical features and management of localized extranodal lymphoma. In: Keating A, Armitage J, Burnet A, Newland A, eds. Hematological Oncology. Vol. 2. Cambridge: Cambridge University Press, 1992:189-223.